CN Patent

CN104523635B — 米拉贝隆缓释药物组合物

Assigned to WANLE PHARMACEUTICAL CO Ltd SHENZHEN · Expires 2017-05-03 · 9y expired

What this patent protects

本发明提供了一种米拉贝隆缓释片，该缓释片的片芯采用羟丙基甲基纤维素为骨架材料，人体口服后能够持续8小时释放，且释放量不小于90%，不使用抗氧剂，保证了药效和安全性。

USPTO Abstract

本发明提供了一种米拉贝隆缓释片，该缓释片的片芯采用羟丙基甲基纤维素为骨架材料，人体口服后能够持续8小时释放，且释放量不小于90%，不使用抗氧剂，保证了药效和安全性。

Drugs covered by this patent

Patent Metadata

Patent number
CN104523635B
Jurisdiction
CN
Classification
—
Expires
2017-05-03
Drug substance claim
No
Drug product claim
No
Assignee
WANLE PHARMACEUTICAL CO Ltd SHENZHEN
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.